ORTEXORTEX News
Live short interest, options flow, and signals — free on ORTEX.Sign up free →
Market Commentary

Earnings Week Puts Big Tech in the Crosshairs

By ORTEX News · Edited by , Editor, ORTEX NewsUpdated 1 min read

Produced automatically from ORTEX data and published under the ORTEX News editorial standards set by Peter Hillerberg, Editor, ORTEX News. How we publish

ShareXLinkedInReddit

Options markets are on edge as a dense earnings slate collides with extreme real-economy signals. Bearish bets dominate activity in chip and AI names. NVDA, AMD and MU are drawing the heaviest negative options flow over the past seven days, per ORTEX screening data.

META sits in the same company. Its RSI has slid to 35.7 and its ORTEX short score stands at 29. Negative bets against the stock rank among the week's largest. Meta reports Q3 results imminently, giving those put positions a near-term catalyst.

TSLA is another name attracting heavy downside flow. The stock is down 17% year-to-date. Its ORTEX short score of 31.7 sits in bearish territory.

Energy names are creating a separate stir. TLN Talen Energy's reactor output fell 10 standard deviations below its own historical norm as of 9 October, the sharpest deviation in the nuclear output dataset. Short interest sits at 5.5% of free float. Any options positioning ahead of operational clarity carries elevated uncertainty.

MSFT and AMZN round out the big-tech earnings queue. Chip names including INTC also report this week. Options players face a compressed window of volatility events. The ORTEX 7-day options score leans positive for health care names like Cigna and insurance names like Allstate. Defensive sector rotation is quietly showing up in the call flow.

Stocks in this article

How this article was generated

Generated
27 Oct 2026, 00:41
Prompt version
v1.0
Data sources
Options flowORTEX Alpha signalsAlt DataIndex Rebalance

ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.